Value creation potential of intellectual capital in biotechnology - Empirical evidence from Finland

R and D Management

Volumn 35, Issue 2, 2005, Pages 171-185

  Hermans, Raine ^a   Kauranen, Ilkka ^b  

^a Elinkeinoelaman Tutkimuslaitos   (Finland)

^b ASIAN INSTITUTE OF TECHNOLOGY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 15944401018     PISSN: 00336807     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1467-9310.2005.00381.x     Document Type: Article

References (29)

1. Ahonen, G. (2000) Generative and commercially exploitable intangible assets. In Classification of Intangibles. CR 712/2000. Paris: HEC School of Management, pp. 206-213.
2. Bontis, N. (2002a) Managing organizational knowledge by diagnosing intellectual capital: Framing and advancing the state of the field. In Bontis, N. (ed.) World Congress on Intellectual Capital Readings, MINT Research Center, McMaster University.
3. Bontis, N. (2002b) National Intellectual Capital Index: Intellectual Capital Development in the Arab Region, United Nations Office for Project Services - McMaster University - IICR, Institute for Intellectual Capital Research Inc., Vancouver 89pp.
4. Bounfour, A. (2002) Measuring intellectual capital's dynamic value: The IC-dVal® approach. In 23rd McMaster World Congress, January 16-18, 2002. Hamilton, ON, Canada. Paper published in conference proceedings CD.
5. Brealey, R.A. and Myers, S.C. (2003) Principles of Corporate Financing (6th ed). New York: McGraw-Hill.
6. Cumby, J. and Conrod, J. (2001) Non-financial performance measures in the Canadian biotechnology industry. Journal of Intellectual Capital, 2, 3, 261-272.
7. Darby, M.R. and Zucker, L.G. (2002) Going public when you can in biotechnology. Working paper 8954, NBER, 35pp.
8. Deeds, D.L. (2001) The role of R&D intensity, technical development and absorptive capacity in creating entrepreneurial wealth in high technology start-ups. Journal of Engineering and Technology Management, 18, 29-47.
9. Edvinsson, L. and Malone, M.S. (1997) Intellectual Capital - The Proven Way to Establish your Company's Real Value by Measuring its Hidden Brainpower. London: Judy Piatkus.
10. Gu, F. and Lev, B. (2001) Intangible assets, measurement, drivers, usefulness. Unpublished discussion paper, Boston University and New York University, 32pp.
11. Guiso, L., Sapienza, P. and Zingales, L. (2001) The role of social capital in financial development. Working paper 511, The Center for Research in Security Prices.
12. Hall, R.E. (2001) The stock market and capital accumulation. American Economie Review, 91, 1155-1202.
13. Hermans, R. and Luukkonen, T. (2002) Findings of the ETLA survey on Finnish biotechnology companies. ETLA discussion paper no. 819 The Research Institute of the Finnish Economy (ETLA), Helsinki, 39pp.
14. Hermans, R. and Tahvanainen, A. (2002) Ownership and financial structures in Finnish biotech SMEs. ETLA discussion paper no. 835, The Research Institute of the Finnish Economy (ETLA), Helsinki, 41pp.
15. Hussi, T. (2001) Aineettoman varallisuuden johtaminen - Miten vastata tunnistamiseen ja kehittämiseen liittyviin haasteisiin (Managing Intangible Assets - How to Answer the Challenges of Identification and Development). Sarja B 180 Series, The Research Institute of the Finnish Economy, ETLA, Helsinki, 67pp (in Finnish).
16. Hussi, T. (2003). Reconfiguring knowledge management. ETLA discussion paper no. 849. The Research Institute of the Finnish Economy (ETLA), Helsinki, 25pp.
17. Hussi, T. and Ahonen, G. (2002) Managing intangible assets - a question of integration and delicate balance. Journal of Intellectual Capital, 3, 3, 277-286.
18. Kuusi, H. (2001) Finland - a European leader in biotechnology. Kemia-Kemi, 28, 432-437.
19. Lev, B. and Sougiannis, T. (1998) The capitalization, amortization, and value-relevance of R&D. In Neef, D., Siesfeld, A. and Cefola, J., The Economic Impact of Knowledge. Boston: Butterworth-Heinemann.
20. Linnosmaa, I., Hermans, R. and Hallinen, T. (2004) Price-cost margin in the pharmaceutical industry: empirical evidence from Finland. The European Journal of Health Economics 5, 2, 122-128.
21. MERITUM Project (2002) Guidelines for Managing and Reporting on Intangibles (Intellectual Capital Report). Madrid: Fundación Airtel Móvil.
22. Mouritsen, J., Bukh, P.N.D., Thorsgaard Larsen, H., Hansen, G., Stakemann, B., Jeppesen, G., Rezai, D., Andersen, B., Kirkegaard, R., Steen and Holm Nielsen, L. (2000) A Guideline for Intellectual Capital Statements - A Key to Knowledge Management. Copenhagen: Danish Agency for Trade and Industry, Ministry of Trade and Industry.
23. Mayo, A. (2001) The Human Value of the Enterprise - Valuing People as Assets, Monitoring, Measuring, Managing. London: Nicholas Brealey Publishing.
24. Nonaka, I. and Takeuchi, H. (1995) The Knowledge-Creating Company. How Japanese Companies Create the Dynamics of Innovation. New York: Oxford University Press.
25. Scherer, F.M. and Ross, D. (1990) Industrial Market Structure and Economic Performance (3rd ed). Boston: Houghton-Mifflin.
26. Sharma, S. (1996) Applied Multivariate Techniques. New York: John Wiley & Sons, Inc.
27. Stewart, T.A. (1997) Intellectual Capital: The New Wealth of Organizations. New York: Doubleday/ Currency, 278pp.
28. Sveiby, K.E. (1990) Kunskapsledning. 101 råd till ledare i kunskapsintensiva organisationer. Stockholm: Affärsvärld förlag.
29. Sveiby, K.E. (1997) The New Organizational Wealth: Managing and Measuring Knowledge-Based Assets. San Francisco: Berrett-Koehler Publishers, Inc., 220pp.